Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ocular-vestibular Biomarker Identification for ADHD

NCT04504890 is registered in ClinicalTrials.gov with Sync-Think, Inc. as lead sponsor.

NCT NCT04504890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04504890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ocular-vestibular Biomarker Identification for ADHD
Lead sponsor
Sync-Think, Inc.
Phase
Observational
Overall status
Unknown status
Start date
July 16, 2020
Completion date
October 5, 2021
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, adhd - combined type, adhd predominantly inattentive type, adhd, predominantly hyperactive - impulsive